Unraveling the Complex Genomic Interplay of Sickle Cell Disease Among the Saudi Population: A Case-Control GWAS Analysis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062817 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ali Alghubayshi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Genome-Wide Association Study, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah International Medical Research Center, KAIMRC.
Abstract (Originalsprache)
Sickle cell disease (SCD) is a severe inherited blood disorder characterized by abnormal hemoglobin (HbS) that leads to varying degrees of severity, including chronic hemolysis, episodic vaso-occlusion, and damage to multiple organs, causing significant morbidity and mortality. While SCD is a monogenic disease, its complications are influenced by polygenic factors. SCD prevalence is notably high in regions including the Middle East, with Saudi Arabia reporting significant cases, particularly in the Eastern Province. Most genetic factors associated with SCD outcomes have been identified in populations predominantly from Africa or of African ancestry. This study aims to identify genetic variants that characterize Saudi SCD patients with the potential to influence disease outcomes in this population. A multicenter case-control genome-wide association study (GWAS) was conducted involving 350 adult Saudi SCD patients and 202 healthy controls. Participants were genotyped using the Affymetrix Axiom array, covering 683,030 markers. Rigorous quality control measures were applied to ensure data integrity. Fisher’s exact was used to identify genetic variants with a significant difference in allele frequency (p < 5 × 10−8). Functional annotations and regulatory functions of variants were determined using the Ensembl Variant Effect Predictor (VEP) and RegulomeDB databases. The GWAS identified numerous significant genetic variants characterizing SCD cases in the Saudi population. These variants, distributed across multiple chromosomes, were found in genes with known functional consequences. A substantial proportion of the markers were detected in the olfactory receptor cluster, TRIM family, and HBB locus genes. Many of the identified genes were reported in previous studies showing significant associations with various SCD outcomes, including hemoglobin regulation, inflammation, immune response, and vascular function. The findings highlight the genetic complexity underlying SCD and its clinical manifestations. The identified variants suggest potential molecular biomarkers and therapeutic targets, enhancing our understanding of the molecular basis of SCD in the Saudi population. This is the first genetic analysis characterizing SCD patients compared to healthy individuals, uncovering genetic markers that could serve as diagnostic biomarkers and therapeutic targets. Given the known molecular mechanisms of the detected genetic loci, these provide a foundation for precision medicine in SCD management, highlighting the need for further studies to validate these results and explore their clinical implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia.
- Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh 11481, Saudi Arabia.
- King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard Health Affairs (MNGHA), Riyadh 11426, Saudi Arabia.
- Hematology/Oncology Center, King Saud University Medical City (KSUMC), Riyadh 11411, Saudi Arabia.
- Research Department, Qatif Central Hospital (QCH), Qatif 32654, Saudi Arabia.
ORCID-Profile: Dayanjan Wijesinghe, Deemah Alwadaani, Farjah H Algahtani, Salah Abohelaika, Hussain H Al Saeed, Abdullah Al Zayed, Abdulmonem Alsaleh
Förderung
- King Abdullah International Medical Research Center
- KAIMRC
Zitieren
APA
Alghubayshi, A., Wijesinghe, D., Alwadaani, D., Algahtani, F. H., Abohelaika, S., Alzahrani, M., Al Saeed, H. H., Al Zayed, A., Alshammari, S., Alhendi, Y., Alsomaie, B., Alsaleh, A., & Alshabeeb, M. A. (2025). Unraveling the Complex Genomic Interplay of Sickle Cell Disease Among the Saudi Population: A Case-Control GWAS Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062817
Vancouver
Alghubayshi A, Wijesinghe D, Alwadaani D, Algahtani FH, Abohelaika S, Alzahrani M, et al. Unraveling the Complex Genomic Interplay of Sickle Cell Disease Among the Saudi Population: A Case-Control GWAS Analysis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062817
BibTeX
@article{Alghubayshi2025,
author = {Alghubayshi, Ali and Wijesinghe, Dayanjan and Alwadaani, Deemah and Algahtani, Farjah H and Abohelaika, Salah and Alzahrani, Mohsen and Al Saeed, Hussain H and Al Zayed, Abdullah and Alshammari, Suad and Alhendi, Yaseen and Alsomaie, Barrak and Alsaleh, Abdulmonem and Alshabeeb, Mohammad A},
title = {Unraveling the Complex Genomic Interplay of Sickle Cell Disease Among the Saudi Population: A Case-Control GWAS Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062817}
}
EUVIMED